Clinical Utility of Antipeptidyl Arginine Deiminase Type 4 Antibodies

J Rheumatol. 2019 Mar;46(3):329-330. doi: 10.3899/jrheum.180905. Epub 2019 Jan 15.

Authors

Erika Darrah¹, Laura Martinez-Prat², Michael Mahler³

Affiliations

¹ Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
² Research and Development, Inova Diagnostics Inc.
³ Research and Development, Inova Diagnostics Inc., San Diego, California, USA. mmahler@inovadx.com m.mahler.job@web.de.

PMID: 30647163
DOI: 10.3899/jrheum.180905

No abstract available

Publication types

Letter
Comment

MeSH terms

Arthritis, Rheumatoid*
Autoantibodies*
Humans
Hydrolases
Protein-Arginine Deiminase Type 4

Substances

Autoantibodies
Hydrolases
Protein-Arginine Deiminase Type 4
arginine deiminase